IBDEI2W1 ; ; 04-FEB-2020
;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
Q:'DIFQR(358.3) F I=1:2 S X=$T(Q+I) Q:X="" S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E S @X=Y
Q Q
;;^UTILITY(U,$J,358.3,46068,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,46068,1,3,0)
;;=3^Vitreous Degeneration (PVD),Bilateral
;;^UTILITY(U,$J,358.3,46068,1,4,0)
;;=4^H43.813
;;^UTILITY(U,$J,358.3,46068,2)
;;=^5005955
;;^UTILITY(U,$J,358.3,46069,0)
;;=H43.812^^176^2297^2
;;^UTILITY(U,$J,358.3,46069,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,46069,1,3,0)
;;=3^Vitreous Degeneration (PVD),Left Eye
;;^UTILITY(U,$J,358.3,46069,1,4,0)
;;=4^H43.812
;;^UTILITY(U,$J,358.3,46069,2)
;;=^5005954
;;^UTILITY(U,$J,358.3,46070,0)
;;=H43.811^^176^2297^1
;;^UTILITY(U,$J,358.3,46070,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,46070,1,3,0)
;;=3^Vitreous Degeneration (PVD),Right Eye
;;^UTILITY(U,$J,358.3,46070,1,4,0)
;;=4^H43.811
;;^UTILITY(U,$J,358.3,46070,2)
;;=^5005953
;;^UTILITY(U,$J,358.3,46071,0)
;;=H43.13^^176^2297^9
;;^UTILITY(U,$J,358.3,46071,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,46071,1,3,0)
;;=3^Vitreous Hemorrhage,Bilateral
;;^UTILITY(U,$J,358.3,46071,1,4,0)
;;=4^H43.13
;;^UTILITY(U,$J,358.3,46071,2)
;;=^5005940
;;^UTILITY(U,$J,358.3,46072,0)
;;=H43.821^^176^2297^10
;;^UTILITY(U,$J,358.3,46072,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,46072,1,3,0)
;;=3^Vitreomacular Adhesion,Right Eye
;;^UTILITY(U,$J,358.3,46072,1,4,0)
;;=4^H43.821
;;^UTILITY(U,$J,358.3,46072,2)
;;=^5005957
;;^UTILITY(U,$J,358.3,46073,0)
;;=H43.822^^176^2297^11
;;^UTILITY(U,$J,358.3,46073,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,46073,1,3,0)
;;=3^Vitreomacular Adhesion,Left Eye
;;^UTILITY(U,$J,358.3,46073,1,4,0)
;;=4^H43.822
;;^UTILITY(U,$J,358.3,46073,2)
;;=^5005958
;;^UTILITY(U,$J,358.3,46074,0)
;;=H43.823^^176^2297^12
;;^UTILITY(U,$J,358.3,46074,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,46074,1,3,0)
;;=3^Vitreomacular Adhesion,Bilateral
;;^UTILITY(U,$J,358.3,46074,1,4,0)
;;=4^H43.823
;;^UTILITY(U,$J,358.3,46074,2)
;;=^5005959
;;^UTILITY(U,$J,358.3,46075,0)
;;=H43.391^^176^2297^15
;;^UTILITY(U,$J,358.3,46075,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,46075,1,3,0)
;;=3^Vitreous Opacities,Right Eye NEC
;;^UTILITY(U,$J,358.3,46075,1,4,0)
;;=4^H43.391
;;^UTILITY(U,$J,358.3,46075,2)
;;=^5005949
;;^UTILITY(U,$J,358.3,46076,0)
;;=H43.392^^176^2297^16
;;^UTILITY(U,$J,358.3,46076,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,46076,1,3,0)
;;=3^Vitreous Opacities,Left Eye NEC
;;^UTILITY(U,$J,358.3,46076,1,4,0)
;;=4^H43.392
;;^UTILITY(U,$J,358.3,46076,2)
;;=^5005950
;;^UTILITY(U,$J,358.3,46077,0)
;;=S05.31XA^^176^2298^1
;;^UTILITY(U,$J,358.3,46077,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,46077,1,3,0)
;;=3^Ocular Laceration w/o Loss of Intraoc Tissue,Right Eye,Init Encntr
;;^UTILITY(U,$J,358.3,46077,1,4,0)
;;=4^S05.31XA
;;^UTILITY(U,$J,358.3,46077,2)
;;=^5020606
;;^UTILITY(U,$J,358.3,46078,0)
;;=S05.32XA^^176^2298^2
;;^UTILITY(U,$J,358.3,46078,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,46078,1,3,0)
;;=3^Ocular Laceration w/o Loss of Intraoc Tissue,Left Eye,Init Encntr
;;^UTILITY(U,$J,358.3,46078,1,4,0)
;;=4^S05.32XA
;;^UTILITY(U,$J,358.3,46078,2)
;;=^5020609
;;^UTILITY(U,$J,358.3,46079,0)
;;=S01.121A^^176^2298^3
;;^UTILITY(U,$J,358.3,46079,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,46079,1,3,0)
;;=3^Laceration w/ FB,Right Eyelid,Init Encntr
;;^UTILITY(U,$J,358.3,46079,1,4,0)
;;=4^S01.121A
;;^UTILITY(U,$J,358.3,46079,2)
;;=^5020066
--- Routine Detail --- with STRUCTURED ROUTINE LISTING ---[H[J[2J[HIBDEI2W1 3748 printed Nov 22, 2024@17:47:05 Page 2
IBDEI2W1 ; ; 04-FEB-2020
+1 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
+2 if 'DIFQR(358.3)
QUIT
FOR I=1:2
SET X=$TEXT(Q+I)
if X=""
QUIT
SET Y=$EXTRACT($TEXT(Q+I+1),4,999)
SET X=$EXTRACT(X,4,999)
if $ASCII(Y)=126
SET I=I+1
SET Y=$EXTRACT(Y,2,999)_$EXTRACT($TEXT(Q+I+1),5,999)
if $ASCII(Y)=61
SET Y=$EXTRACT(Y,2,999)
XECUTE NO
IF '$TEST
SET @X=Y
Q QUIT
+1 ;;^UTILITY(U,$J,358.3,46068,1,0)
+2 ;;=^358.31IA^4^2
+3 ;;^UTILITY(U,$J,358.3,46068,1,3,0)
+4 ;;=3^Vitreous Degeneration (PVD),Bilateral
+5 ;;^UTILITY(U,$J,358.3,46068,1,4,0)
+6 ;;=4^H43.813
+7 ;;^UTILITY(U,$J,358.3,46068,2)
+8 ;;=^5005955
+9 ;;^UTILITY(U,$J,358.3,46069,0)
+10 ;;=H43.812^^176^2297^2
+11 ;;^UTILITY(U,$J,358.3,46069,1,0)
+12 ;;=^358.31IA^4^2
+13 ;;^UTILITY(U,$J,358.3,46069,1,3,0)
+14 ;;=3^Vitreous Degeneration (PVD),Left Eye
+15 ;;^UTILITY(U,$J,358.3,46069,1,4,0)
+16 ;;=4^H43.812
+17 ;;^UTILITY(U,$J,358.3,46069,2)
+18 ;;=^5005954
+19 ;;^UTILITY(U,$J,358.3,46070,0)
+20 ;;=H43.811^^176^2297^1
+21 ;;^UTILITY(U,$J,358.3,46070,1,0)
+22 ;;=^358.31IA^4^2
+23 ;;^UTILITY(U,$J,358.3,46070,1,3,0)
+24 ;;=3^Vitreous Degeneration (PVD),Right Eye
+25 ;;^UTILITY(U,$J,358.3,46070,1,4,0)
+26 ;;=4^H43.811
+27 ;;^UTILITY(U,$J,358.3,46070,2)
+28 ;;=^5005953
+29 ;;^UTILITY(U,$J,358.3,46071,0)
+30 ;;=H43.13^^176^2297^9
+31 ;;^UTILITY(U,$J,358.3,46071,1,0)
+32 ;;=^358.31IA^4^2
+33 ;;^UTILITY(U,$J,358.3,46071,1,3,0)
+34 ;;=3^Vitreous Hemorrhage,Bilateral
+35 ;;^UTILITY(U,$J,358.3,46071,1,4,0)
+36 ;;=4^H43.13
+37 ;;^UTILITY(U,$J,358.3,46071,2)
+38 ;;=^5005940
+39 ;;^UTILITY(U,$J,358.3,46072,0)
+40 ;;=H43.821^^176^2297^10
+41 ;;^UTILITY(U,$J,358.3,46072,1,0)
+42 ;;=^358.31IA^4^2
+43 ;;^UTILITY(U,$J,358.3,46072,1,3,0)
+44 ;;=3^Vitreomacular Adhesion,Right Eye
+45 ;;^UTILITY(U,$J,358.3,46072,1,4,0)
+46 ;;=4^H43.821
+47 ;;^UTILITY(U,$J,358.3,46072,2)
+48 ;;=^5005957
+49 ;;^UTILITY(U,$J,358.3,46073,0)
+50 ;;=H43.822^^176^2297^11
+51 ;;^UTILITY(U,$J,358.3,46073,1,0)
+52 ;;=^358.31IA^4^2
+53 ;;^UTILITY(U,$J,358.3,46073,1,3,0)
+54 ;;=3^Vitreomacular Adhesion,Left Eye
+55 ;;^UTILITY(U,$J,358.3,46073,1,4,0)
+56 ;;=4^H43.822
+57 ;;^UTILITY(U,$J,358.3,46073,2)
+58 ;;=^5005958
+59 ;;^UTILITY(U,$J,358.3,46074,0)
+60 ;;=H43.823^^176^2297^12
+61 ;;^UTILITY(U,$J,358.3,46074,1,0)
+62 ;;=^358.31IA^4^2
+63 ;;^UTILITY(U,$J,358.3,46074,1,3,0)
+64 ;;=3^Vitreomacular Adhesion,Bilateral
+65 ;;^UTILITY(U,$J,358.3,46074,1,4,0)
+66 ;;=4^H43.823
+67 ;;^UTILITY(U,$J,358.3,46074,2)
+68 ;;=^5005959
+69 ;;^UTILITY(U,$J,358.3,46075,0)
+70 ;;=H43.391^^176^2297^15
+71 ;;^UTILITY(U,$J,358.3,46075,1,0)
+72 ;;=^358.31IA^4^2
+73 ;;^UTILITY(U,$J,358.3,46075,1,3,0)
+74 ;;=3^Vitreous Opacities,Right Eye NEC
+75 ;;^UTILITY(U,$J,358.3,46075,1,4,0)
+76 ;;=4^H43.391
+77 ;;^UTILITY(U,$J,358.3,46075,2)
+78 ;;=^5005949
+79 ;;^UTILITY(U,$J,358.3,46076,0)
+80 ;;=H43.392^^176^2297^16
+81 ;;^UTILITY(U,$J,358.3,46076,1,0)
+82 ;;=^358.31IA^4^2
+83 ;;^UTILITY(U,$J,358.3,46076,1,3,0)
+84 ;;=3^Vitreous Opacities,Left Eye NEC
+85 ;;^UTILITY(U,$J,358.3,46076,1,4,0)
+86 ;;=4^H43.392
+87 ;;^UTILITY(U,$J,358.3,46076,2)
+88 ;;=^5005950
+89 ;;^UTILITY(U,$J,358.3,46077,0)
+90 ;;=S05.31XA^^176^2298^1
+91 ;;^UTILITY(U,$J,358.3,46077,1,0)
+92 ;;=^358.31IA^4^2
+93 ;;^UTILITY(U,$J,358.3,46077,1,3,0)
+94 ;;=3^Ocular Laceration w/o Loss of Intraoc Tissue,Right Eye,Init Encntr
+95 ;;^UTILITY(U,$J,358.3,46077,1,4,0)
+96 ;;=4^S05.31XA
+97 ;;^UTILITY(U,$J,358.3,46077,2)
+98 ;;=^5020606
+99 ;;^UTILITY(U,$J,358.3,46078,0)
+100 ;;=S05.32XA^^176^2298^2
+101 ;;^UTILITY(U,$J,358.3,46078,1,0)
+102 ;;=^358.31IA^4^2
+103 ;;^UTILITY(U,$J,358.3,46078,1,3,0)
+104 ;;=3^Ocular Laceration w/o Loss of Intraoc Tissue,Left Eye,Init Encntr
+105 ;;^UTILITY(U,$J,358.3,46078,1,4,0)
+106 ;;=4^S05.32XA
+107 ;;^UTILITY(U,$J,358.3,46078,2)
+108 ;;=^5020609
+109 ;;^UTILITY(U,$J,358.3,46079,0)
+110 ;;=S01.121A^^176^2298^3
+111 ;;^UTILITY(U,$J,358.3,46079,1,0)
+112 ;;=^358.31IA^4^2
+113 ;;^UTILITY(U,$J,358.3,46079,1,3,0)
+114 ;;=3^Laceration w/ FB,Right Eyelid,Init Encntr
+115 ;;^UTILITY(U,$J,358.3,46079,1,4,0)
+116 ;;=4^S01.121A
+117 ;;^UTILITY(U,$J,358.3,46079,2)
+118 ;;=^5020066
